Search This Blog

Showing posts with label KATHLEEN RICE. Show all posts
Showing posts with label KATHLEEN RICE. Show all posts

Wednesday, October 20, 2021

RSN: FOCUS: Robert Reich | Why the Hell Are Democrats Keeping Your Drug Prices High?

 


 

Reader Supported News
20 October 21

Live on the homepage now!
Reader Supported News

AGAIN TODAY: 3 DONATIONS $75, SO FAR — That is the root of the fundraising agony. Yes regrettably it does appear that most of the people who come to Reader Supported News are ignoring fundraising. Struggling for a reasonable response.
Marc Ash • Founder, Reader Supported News

Sure, I'll make a donation!

 

Robert Reich. (photo: Steve Russell/Toronto Star)
FOCUS: Robert Reich | Why the Hell Are Democrats Keeping Your Drug Prices High?
Robert Reich, Robert Reich's Website
Reich writes: "Oh, and pharmaceutical firms have been overflowing with so much cash they’ve been buying back their own shares of stock."

Why the hell are Democrats keeping your drug prices high?

Excuse me but I have to vent.

Three House Democrats and one Democratic senator are now blocking a proposal to allow Medicare to negotiate drug prices. Medicare is such a big purchaser of drugs that it has the bargaining leverage to cut drug prices for everyone — if allowed to do so. This would save at least $450 billion over the next 10 years and significantly lower prescription drug prices.

But four Democrats are standing in the way.

Before I get to why they’re doing this, let me identify them. In the House: Scott Peters (whose district includes San Diego), Kurt Schrader (Oregon’s central coast), and Kathleen Rice (central and southern Nassau County on Long Island).

And in the Senate: Kyrsten Sinema (Arizona).

Okay, so why are these four Democrats blocking this measure?

Not because this policy is unpopular with the public. To the contrary, 88 percent of voters favor allowing the federal government to negotiate lower drug prices, including 77 percent of Republicans.

In fact, at least 90 percent of these four lawmakers’ own constituents support allowing Medicare to negotiate drug prices. Get this: The idea is so popular that both Kathleen Rice and Kyrsten Sinema actively campaigned on it.

And not because the pharmaceutical industry needs extra money in order to continue to generate new drugs. Taxpayers already fund much of its basic research through the National Institutes of Health. Also bear in mind that a big portion of the costs of bringing a drug to market goes into advertising and marketing — which shouldn’t even be allowed for prescription drugs (and isn’t in most other rich countries, and wasn’t in the US until Big Pharma lobbied for the law to change).

Oh, and pharmaceutical firms have been overflowing with so much cash they’ve been buying back their own shares of stock.

In other words, allowing Medicare to negotiate lower drug prices should be a no-brainer.

So what gives? The question should be who gives. Follow the money.

From 2019 to 2020, Kyrsten Sinema received over $120,000 in Big Pharma contributions, even though she’s not up for re-election until 2024. Throughout her political career, she’s taken over half a million dollars from Pharma PACs and executives. Just before Sinema officially came out publicly against allowing Medicare to negotiate drug prices, a group bankrolled by Big Pharma began running TV and digital ads and sending mailers praising her for “fighting as an independent voice.”

If you think this was a coincidence, I have a bridge in Brooklyn to sell you.

Scott Peters, meanwhile, happens to be the House’s single biggest recipient of Big Pharma campaign cash in the 2022 election cycle so far. Since being elected in 2012, Peters has socked away over $860,000 from Big Pharma. The day after his letter to House Speaker Nancy Pelosi opposing using Medicare to negotiate lower drug prices was published in May 2021, Peters began receiving thousands of donations from executives at pharmaceutical companies and the industry’s powerful lobbying group.

Another coincidence? P-l-e-a-s-e.

Kurt Schrader has raked in nearly $615,000 from Big Pharma since taking office in 2008. This election cycle he’s already got $24,500 from Pharma PACS, the second most of any industry donating to him. One of former his top aides left his office earlier this year and is now lobbying for Big Pharma. According to ethics disclosures, the former aide’s lobbying efforts focus on … guess what? Drug pricing.

The third House Democrat, Kathleen Rice, has received over $84,000 from Big Pharma.

The grand total of Big Pharma cash going to these four lawmakers: over $2 million. When you consider the billions that Big Pharma will rake in for keeping drug prices high, this is a small potatoes for them. You might even call it a great investment.

But it’s a huge cost for the rest of us.

The measure isn’t being blocked solely because these four Democrats oppose it. No Republican members of Congress are in support.

But it does seem odd that Democrats would stand in the way of this sort of reform, rebuffing their own president and party — and rejecting the overwhelming preference of voters, including their own constituents — to tank a policy that they themselves campaigned on. I mean, what’s the Democratic Party for if it won’t reduce drug prices for average people? Why were these four Democrats elected in the first place?

Sometimes I worry that pointing out this sort of corruption (and it is a form of corruption) will make people even more cynical than they already are about American politics, resulting in a kind of fatalism or resignation that causes many to give up — and thereby cede the entirety of our democracy to the moneyed interests. My hope is just the opposite: that when people hear about this sort of thing, they’re outraged enough to become even more politically active.

In my experience spanning fifty years of American politics — from interning for Senator Bobby Kennedy in 1967 to serving as secretary of labor in the Clinton administration to advising President Obama — most of the elected lawmakers I’ve dealt with sincerely want to do the right thing. Some don’t feel they can do the right thing if they want to be reelected, and confuse means and ends. A very few are on the take.

By which I mean to say that the situation is hardly hopeless. I refuse to give up on democracy. And I won’t give up on the Democratic Party. But I’m only going to fight for candidates from the Democratic side of the Democratic Party.

What can you do? For one thing, contact your members of Congress and tell them that the first step in getting big money out of politics is to support the Freedom to Vote Act. (You might put in an extra call to Joe Manchin’s office and say you expect him to deliver 10 Republican senators’ votes for this bill — which he helped author — or else agree to reform the filibuster to let voting rights bills be enacted with a bare majority.)

Here’s something else you can do: If you happen to be a constituent of one of these four Democrats, don’t vote for them when they’re up for reelection. Make sure they’re primaried, and then vote in the Democratic primaries for true public servants — who care more about advancing the public good than protecting private profits.


READ MORE

 

Contribute to RSN

Follow us on facebook and twitter!

Update My Monthly Donation

PO Box 2043 / Citrus Heights, CA 95611






Monday, October 4, 2021

RSN: FOCUS: Andrew Perez | Big Pharma Is Showering Conservative House Democrats With Gushing Ads

 


 

Reader Supported News

Live on the homepage now!
Reader Supported News

AN URGENT DRIVE TO FINISH SEPTEMBER: We are pushing very hard to finish the September funding drive. This money allows RSN to continue keeping you up to date on information the main stream media glosses over. Without adequate funding RSN cannot continue to have that impact it now has, and that you rely on. Make your contribution today.
Marc Ash • Founder, Reader Supported News

Sure, I'll make a donation!

 

California representative Scott Peters. (photo: Chris Stone/Times of San Diego)
FOCUS: Andrew Perez | Big Pharma Is Showering Conservative House Democrats With Gushing Ads
Andrew Perez, Jacobin
Perez writes: "A dark money group funded by Big Pharma is bankrolling ads boosting the conservative House Democrats who are trying to weaken the party's plan to allow Medicare to negotiate lower drug prices."

A front group for Big Pharma is running ads backing the House Democrats who are trying to gut the party’s plan to cut drug prices.

A dark money group funded by Big Pharma is bankrolling ads boosting the conservative House Democrats who are trying to weaken the party’s plan to allow Medicare to negotiate lower drug prices. Additionally, a separate pharma-funded foundation is suddenly sponsoring newspaper ads thanking one of the Democrats for his work on prescription drug policy.

The new ad campaigns highlight the lengths the pharmaceutical industry is willing to go in order to derail legislation that could cut into their bottom line. If Big Pharma’s efforts are successful, it will prevent the government from saving tens of billions annually and stop health care reforms that would cut prices on expensive drugs by more than 50 percent.

Last week, the Washington-based nonprofit Center Forward started running digital ads touting six Democratic lawmakers who are trying to replace Democrats’ long-promised prescription drug pricing bill with far weaker provisions: Representatives Scott Peters (CA), Kurt Schrader (OR), Kathleen Rice (NY), Stephanie Murphy (FL), Lou Correa (CA), and Josh Gottheimer (NJ).

Four of the Democrats supported by the ads — Peters, Schrader, Rice, and Murphy — recently used their committee positions to try to block House leaders from including the drug pricing legislation in the party’s $3.5 trillion reconciliation package. While House Democrats have kept the drug pricing measure in their reconciliation bill so far, Democrats only currently have a four-seat majority in the House, so they can only afford to lose three votes on the package.

Center Forward, who says its mission is “to give centrist allies the information they need to craft common sense solutions,” is heavily funded by Big Pharma. Washington’s top drug lobby, Pharmaceutical Research and Manufacturers of America (PhRMA), donated $4.5 million to Center Forward between 2016 and 2019, accounting for a quarter of its revenue, tax records show.

According to data from AdImpact, Center Forward has separately spent about $600,000 on TV and radio ads promoting Senator Kyrsten Sinema (D-AZ). The group’s pro-Sinema ad campaign started days before she told the White House she does not support Democratic leaders’ Medicare drug negotiation plan or the more limited proposal from Peters. The Senate is split fifty-fifty, so opposition from Sinema would effectively kill it.

The six Democratic lawmakers have collected a combined $2.2 million from donors in the pharmaceutical and health products industries during their careers, according to OpenSecrets, while Sinema has raised more than $500,000. Peters is the top recipient of drug industry cash in the House so far this year.

Conservative Democrats Flipped on Drug Measure

House Democrats’ drug pricing provision is based on H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, and would allow Medicare to use its bulk purchasing power to negotiate lower prescription drug prices. According to the Congressional Budget Office, H.R. 3’s drug pricing provision would save the government $456 billion over ten years and “reduce prices by 57 percent to 75 percent, relative to current prices” for various medicines.

Correa, Gottheimer, Murphy, Peters, Rice, and Schrader all voted yes on H.R. 3 in 2019, when it passed the House with no opposition in the Democratic caucus.

Now, Murphy, who cochairs the conservative Blue Dog Coalition, as well as Peters, Rice, and Schrader have all voted against the measure in committee. The lawmakers, along with Correa and Gottheimer, are instead pushing a significantly weaker proposal.

Democratic leaders’ drug pricing measure would allow Medicare to negotiate prices on twenty-five high-priced drugs in the first year of implementation, and fifty drugs in subsequent years. The Peters legislation would only allow Medicare to negotiate prices on older drugs that have lost exclusivity rights but don’t have any generic competition.

Peters recently defended his proposal in a meeting with constituents, saying it would generate $200 billion in savings “using pharma profits.” He warned that Democrats’ plan to recoup $450 billion in drug company profits over a decade would destroy the industry. In reality, it would only affect a fraction of bloated drug company profits.

Schrader told a local TV station: “If pharma thinks they’re buying a vote, they’re getting a bad deal. This bill that [Peters] and I are offering, not only is it dangerous for pharma because it has a chance of passing, but it’s more complete and more in-depth.”

“We All Can Use a Little Good News”

While Center Forward has specifically chosen to praise the Democrats backing an alternative drug pricing measure, their ads don’t actually mention that bill.

Instead, the ads thank the lawmakers for working to pass the Senate’s industry-friendly, bipartisan infrastructure deal.

“We all can use a little good news, can’t we? That’s what Representative Scott Peters has been delivering to us,” says one of the ads. “Working to pass jobs and family legislation that prioritizes our economy and quality of life. It invests in desperately needed improvements to our infrastructure and transportation systems. And it creates jobs. Good paying jobs. Right here. We know we can always count on Scott Peters to deliver. So thank him and ask him to keep fighting for jobs and families.”

Gottheimer and Schrader were among the nine conservative House Democrats who pushed Democratic leaders to schedule a vote on the bipartisan infrastructure deal this week.

The point was to de-link the bipartisan infrastructure legislation from Democrats’ broader, $3.5 trillion reconciliation spending bill, which is meant to finance President Biden’s economic, health, and climate agenda.

Progressive lawmakers have threatened to vote down the bipartisan infrastructure bill unless Senate Democrats first pass the reconciliation bill. The Congressional Progressive Caucus has said it has the votes to block the bipartisan deal.

Sinema is now reportedly threatening to take down both infrastructure measures — the bipartisan one she helped negotiate and the reconciliation package — if House Democrats block or delay the bipartisan bill.

Corporate Influence

Center Forward is an ostensibly “centrist” political advocacy organization, but it’s better understood as a front group for corporate interests. Its board is stacked with corporate lobbyists, including lobbyists for PhRMA.

In addition to its substantial funding from PhRMA, Center Forward has received corporate donations from pharmacy giant CVS Health (which owns health insurer Aetna), oil and gas company ConocoPhillips, electric utility PG&E, as well as Coca-Cola and Facebook. The dark money group has also received contributions from the National Restaurant Association, a lobbying group for big restaurant chains.

Another group funded by PhRMA has been buying ads promoting Peters in a local newspaper.

The Lupus Foundation of America has run ads twice in the San Diego Union-Tribune in recent days. (The Daily Poster was alerted to the ads by a subscriber.) The Lupus Foundation of America received $1.6 million from PhRMA between 2011–19, tax records show.

“Thank you Congressman Scott Peters for leading the fight to lower drug costs for patients,” the ads say. “Managing any illness can be difficult. People living with lupus take an average of 8 prescription drugs.”


READ MORE

 

Contribute to RSN

Follow us on facebook and twitter!

Update My Monthly Donation

PO Box 2043 / Citrus Heights, CA 95611






"Look Me In The Eye" | Lucas Kunce for Missouri

  Help Lucas Kunce defeat Josh Hawley in November: https://LucasKunce.com/chip-in/ Josh Hawley has been a proud leader in the fight to ...